5.84
-0.15(-2.50%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
572
First IPO Date
February 03, 1999
| Name | Title | Pay | Year Born |
| Hongshan Ye | Chief Accounting Officer | 0 | N/A |
| Mr. Xiang Wu Ye | Chairman of the Board, GM & Chief Financial Officer | 0 | 1952 |
| Ms. Yuan Bi | Board Secretary, Vice President & Director | 0 | 1988 |
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. The company was founded in 2003 and is headquartered in Shanghai, China.